Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Immunotargets and Therapy|June 6, 2017
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetesArata Itoh, William M RidgwayEndocrine Journal|May 31, 2023
Impact of coronavirus disease 2019 in seasonal variation of hemoglobin A1c in adults with type 1 diabetes and the effect of the mode of treatment: a single-center retrospective study for 2019 and 2021 and analysis by the mode of treatmentKarin Tanaka, Shu Meguro, Arata Itoh, et al.Upsala Journal of Medical Sciences|January 18, 2012
A case of hypoglycemic hemiparesis and literature reviewTetsuhiro Yoshino, Shu Meguro, Yukie Soeda, et al.Diabetology International|August 5, 2024
A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetesRie Kaneshima Tamura, Noriko Kodani, Arata Itoh, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2021
Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic PeptidesMeng Li, Arata Itoh, Jingchao Xi, et al.Journal of Diabetes Investigation|January 28, 2022
Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case reportHironobu Sasaki, Arata Itoh, Yasuhiro Watanabe, et al.Endocrine Journal|October 30, 2015
Time-dependent changes in insulin requirement for maternal glycemic control during antenatal corticosteroid therapy in women with gestational diabetes: a retrospective studyArata Itoh, Yoshifumi Saisho, Kei Miyakoshi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2017
CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD MiceMatthew H Forsberg, Ashley E Ciecko, Kyle J Bednar, et al.The Journal of Medical Investigation : JMI|October 27, 2024
Difference in the accuracy of the third-generation algorithm and the first-generation algorithm of FreeStyle Libre continuous glucose monitoring deviceTakashi Murata, Naoki Sakane, Yushi Hirota, et al.Frontiers in Immunology|December 3, 2019
Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell AnergyArata Itoh, Lorenzo Ortiz, Kritika Kachapati, et al.Pageof 2